by Igor Hajdukovic | Oct 3, 2026 | Uncategorized
What if the most important safeguard against a plasma pen complication is a decision made before the device is switched on? For clinicians, avoiding plasma pen complications in a clinical setting starts with more than careful technique. Patient suitability,...
by Igor Hajdukovic | Oct 2, 2026 | Uncategorized
“Plasma” doesn’t describe one procedure. Plasma skin regeneration, plasma pen treatments and platelet-rich plasma (PRP) differ in how they work, what patients may experience and which clinical details apply. Clear patient education materials for plasma skin...
by Igor Hajdukovic | Oct 1, 2026 | Uncategorized
A Health Canada-licensed plasma pen does not, by itself, establish that a practitioner is authorized to perform a treatment. That distinction is central to plasma pen training requirements Canada: device licensing addresses a device’s status for sale, while...
by Igor Hajdukovic | Sep 30, 2026 | Uncategorized
What if the most important part of a non-surgical procedure happens before treatment begins? Patients may hope for immediate, uniform or lasting results, yet outcomes and recovery can vary. Managing patient expectations for non-surgical procedures means addressing...
by Igor Hajdukovic | Sep 29, 2026 | Uncategorized
A signed consent form can document a decision without showing whether the patient understood the procedure. For clinics seeking patient consent forms for plasma therapy Canada, the form should support a clear, procedure-specific discussion, not function as a generic...
by Igor Hajdukovic | Sep 28, 2026 | Uncategorized
A “high precision” label doesn’t establish clinical suitability. Assess a high precision plasma pen by how its technology and controls support the intended use, not by product-page language alone. That distinction matters when professional medical devices and consumer...
